Vascular calcification inhibitors in chronic kidney disease
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.
In vitro adsorption of direct oral anticoagulants from patient plasma samples
Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
Implementation of laboratory approach for persons with hemophilia requiring DOAC therapy.
Tavapraktikal põhinev tervishoiuteadus: lühiülevaade pragmaatilistest uuringutest
Laboratory Options for Assessing the Effects of Direct Oral Anticoagulants in Estonia
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
In-phase matrix profile: A novel method for the detection of major depressive disorder
Lipid-Lowering Treatment Gaps in Patients after Acute Myocardial Infarction: Using Global Database TriNetX
Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study